Luis G. Ares-Rodriguez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-Making.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Modelling and Implementation of a Precision-Oncology Data-Integration Platform for Real-Word Molecular Tumor Borad Decision-Making.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.
Journal: The New England journal of medicine
Published: March 25, 2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 17, 2025
INGENIO-DQ: Data Quality Assessment for a Precison Medicine Data Model Using an International Common Framework.
Journal: Studies in health technology and informatics
Published: May 17, 2025
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: April 01, 2025
Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 06, 2025
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer.
Journal: Nature medicine
Published: January 27, 2025
Sotorasib versus docetaxel: evidence supporting CodeBreaK 200.
Journal: The Lancet. Oncology
Published: June 16, 2024
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: October 05, 2023
Sotorasib in KRASG12C mutated lung cancer - Authors' reply.
Journal: Lancet (London, England)
Published: September 06, 2023
Last Updated: 09/26/2026